Contact
searchSearch
HMP Global

News

News
Oral Icotrokinra Demonstrates High Efficacy and Favorable Safety in Plaque Psoriasis
05/12/2026
Jessica Garlewicz
Investigators analyzed 5 randomized trials including 1951 patients receiving icotrokinra 200 mg once daily or placebo.
Investigators analyzed 5 randomized trials including 1951 patients receiving icotrokinra 200 mg once daily or placebo.
Investigators analyzed 5...
05/12/2026
The Dermatologist
News
Icotrokinra Demonstrates Biologic-Level Efficacy With Oral Administration in Psoriasis
05/12/2026
Jessica Garlewicz
Icotrokinra, an oral interleukin-23 receptor (IL-23R) antagonist, may offer efficacy comparable to biologic therapies in moderate-to-severe plaque psoriasis.
Icotrokinra, an oral interleukin-23 receptor (IL-23R) antagonist, may offer efficacy comparable to biologic therapies in moderate-to-severe plaque psoriasis.
Icotrokinra, an oral...
05/12/2026
The Dermatologist
News
Oral Icotrokinra Shows Rapid Efficacy Across Skin and Scalp Psoriasis With Favorable Safety
05/12/2026
Jessica Garlewicz
Investigators analyzed five randomized trials including 1509 patients treated with icotrokinra and compared outcomes with placebo.
Investigators analyzed five randomized trials including 1509 patients treated with icotrokinra and compared outcomes with placebo.
Investigators analyzed five...
05/12/2026
The Dermatologist
News
Machine Learning Identifies Potential Dual-Target Compounds for Atopic Dermatitis
05/05/2026
Jessica Garlewicz
Machine learning–based modeling may accelerate the discovery of novel therapies for atopic dermatitis by identifying compounds that simultaneously activate key anti-inflammatory pathways.
Machine learning–based modeling may accelerate the discovery of novel therapies for atopic dermatitis by identifying compounds that simultaneously activate key anti-inflammatory pathways.
Machine learning–based modeling...
05/05/2026
The Dermatologist
News
Cutaneous Pain in Atopic Dermatitis Linked to Higher Psychological Burden
05/05/2026
Jessica Garlewicz
Cutaneous pain in atopic dermatitis is strongly associated with increased anxiety, depression, stigmatization, and impaired quality of life.
Cutaneous pain in atopic dermatitis is strongly associated with increased anxiety, depression, stigmatization, and impaired quality of life.
Cutaneous pain in atopic...
05/05/2026
The Dermatologist
News
POEM Scores Align With Clinical Severity and Treatment Intensity in Pediatric Atopic Dermatitis
05/05/2026
Jessica Garlewicz
The Patient-Oriented Eczema Measure (POEM) may provide a practical and reliable assessment of disease severity in pediatric atopic dermatitis.
The Patient-Oriented Eczema Measure (POEM) may provide a practical and reliable assessment of disease severity in pediatric atopic dermatitis.
The Patient-Oriented Eczema...
05/05/2026
The Dermatologist
News
New Visual Scale Aims to Standardize Nail Psoriasis Severity Assessment
05/05/2026
Jessica Garlewicz
A newly developed visual tool may improve consistency in assessing fingernail psoriasis severity, addressing a longstanding gap in clinical trials and practice.
A newly developed visual tool may improve consistency in assessing fingernail psoriasis severity, addressing a longstanding gap in clinical trials and practice.
A newly developed visual tool...
05/05/2026
The Dermatologist
News
Macrophage-Focused Psoriasis Research Shifts Toward Precision Therapeutics
05/05/2026
Jessica Garlewicz
Research on macrophages in psoriasis has expanded over the past decade, with increasing emphasis on translational applications and precision medicine, according to a bibliometric analysis of global scientific output.
Research on macrophages in psoriasis has expanded over the past decade, with increasing emphasis on translational applications and precision medicine, according to a bibliometric analysis of global scientific output.
Research on macrophages in...
05/05/2026
The Dermatologist
News
Lifestyle and Behavioral Interventions Show Adjunctive Potential in Psoriasis Management
05/05/2026
Jessica Garlewicz
Non-pharmacological interventions, including diet, exercise, and psychological support, may offer complementary benefits in psoriasis management, although evidence remains heterogeneous and insufficient to replace standard therapy.
Non-pharmacological interventions, including diet, exercise, and psychological support, may offer complementary benefits in psoriasis management, although evidence remains heterogeneous and insufficient to replace standard therapy.
Non-pharmacological...
05/05/2026
The Dermatologist
News
IL23R Variant Shows Protective Association in Psoriasis Susceptibility Study
05/05/2026
Jessica Garlewicz
A genetic variant in the IL23R gene may confer protection against psoriasis in an Eastern European population, reinforcing the central role of the IL-23/Th17 pathway in disease pathogenesis.
A genetic variant in the IL23R gene may confer protection against psoriasis in an Eastern European population, reinforcing the central role of the IL-23/Th17 pathway in disease pathogenesis.
A genetic variant in the IL23R...
05/05/2026
The Dermatologist

Popular Articles

Atopic dermatitis
News
Arcutis Presents Long-Term Data on Roflumilast Cream for Atopic Dermatitis
06/11/2024
Riya Gandhi, MA
At the Revolutionizing Alopecia Areata, Vitiligo, and Eczema Conference, Arcutis Biotherapeutics, Inc., unveiled new findings from the INTEGUMENT-OLE long-term open-label study of roflumilast cream 0.15% for adults and children with atopic...
At the Revolutionizing Alopecia Areata, Vitiligo, and Eczema Conference, Arcutis Biotherapeutics, Inc., unveiled new findings from the INTEGUMENT-OLE long-term open-label study of roflumilast cream 0.15% for adults and children with atopic...
At the Revolutionizing Alopecia...
06/11/2024
The Dermatologist
psoriatic arthritis
News
Vaccination Recommendations for Patients Receiving Antipsoriatic Systemic Therapies
07/26/2024
Jessica Garlewicz
Researchers aimed to evaluate the literature on vaccine efficacy and safety, using a modified Delphi process to generate 22 consensus-based recommendations for adults receiving systemic therapies for psoriasis.
Researchers aimed to evaluate the literature on vaccine efficacy and safety, using a modified Delphi process to generate 22 consensus-based recommendations for adults receiving systemic therapies for psoriasis.
Researchers aimed to evaluate...
07/26/2024
The Dermatologist
Cover Story
Navigating Women’s Health Dermatology Through Life’s Stages
09/06/2024
Jennifer Foster, BS; Melissa Mauskar, MD
By addressing specific needs at each stage, dermatologists can provide comprehensive and empathetic care, enhancing both the health and confidence of their patients.
By addressing specific needs at each stage, dermatologists can provide comprehensive and empathetic care, enhancing both the health and confidence of their patients.
By addressing specific needs at...
09/06/2024
The Dermatologist
acne
News
The Relationship Between Acne Vulgaris and Metabolic Syndrome
05/13/2024
Jessica Garlewicz
Could the mechanistic Target of Rapamycin have a potential role in explaining the relationship between acne vulgaris and metabolic syndrome in acne pathogenesis?
Could the mechanistic Target of Rapamycin have a potential role in explaining the relationship between acne vulgaris and metabolic syndrome in acne pathogenesis?
Could the mechanistic Target of...
05/13/2024
The Dermatologist
Atopic dermatitis
News
Lebrikizumab for Moderate to Severe Atopic Dermatitis in Patients Age ≥60 Years
06/20/2024
Jessica Garlewicz
Atopic dermatitis (AD) significantly impacts adults, with a meta-analysis showing that 26.1% of AD cases have an onset after age 16 years.
Atopic dermatitis (AD) significantly impacts adults, with a meta-analysis showing that 26.1% of AD cases have an onset after age 16 years.
Atopic dermatitis (AD)...
06/20/2024
The Dermatologist
April/May 2026 cover

Current Issue

May 2026
Volume 34
Issue 3
Current Issue
Issue Archive

Latest Quizzes and Trivia

Quiz
Predicting Disease Severity and Persistence in Pediatric Atopic Dermatitis
04/15/2026
Riya Gandhi, MA
Test your expertise in identifying risk factors for persistent pediatric atopic dermatitis and understanding the interplay between barrier dysfunction and immune dysregulation.
Test your expertise in identifying risk factors for persistent pediatric atopic dermatitis and understanding the interplay between barrier dysfunction and immune dysregulation.
Test your expertise in...
04/15/2026
The Dermatologist
Quiz
Type 2 Inflammation and Early Systemic Therapy in Pediatric Atopic Dermatitis
04/05/2026
Riya Gandhi, MA
Assess advanced clinical reasoning in pediatric atopic dermatitis, including implications of type 2 inflammation for diagnosis, treatment timing, and systemic therapy decisions.
Assess advanced clinical reasoning in pediatric atopic dermatitis, including implications of type 2 inflammation for diagnosis, treatment timing, and systemic therapy decisions.
Assess advanced clinical...
04/05/2026
The Dermatologist
Quiz
Disease Heterogeneity in PN
03/15/2026
Riya Gandhi, MA
Challenge your understanding of direct and indirect cytokine–nerve interactions and mechanical hypersensitivity of type 2 signaling in prurigo nodularis.
Challenge your understanding of direct and indirect cytokine–nerve interactions and mechanical hypersensitivity of type 2 signaling in prurigo nodularis.
Challenge your understanding of...
03/15/2026
The Dermatologist
Quiz
Rethinking Severity and JAK Inhibitor Strategy in Alopecia Areata
03/12/2026
Riya Gandhi, MA
How should clinicians redefine severe alopecia areata? When is it appropriate to treat ≤20% scalp involvement with oral JAK inhibitors? This expert-level quiz explores remission durability, treatment withdrawal, and practical strategies for...
How should clinicians redefine severe alopecia areata? When is it appropriate to treat ≤20% scalp involvement with oral JAK inhibitors? This expert-level quiz explores remission durability, treatment withdrawal, and practical strategies for...
How should clinicians redefine...
03/12/2026
The Dermatologist
Quiz
Cytokine Hierarchy and Sustained Pruritus in PN
03/10/2026
Riya Gandhi, MA
Explore the hierarchical and cooperative roles of IL-4, IL-13, and IL-31 in sustaining chronic itch and inflammation in prurigo nodularis.
Explore the hierarchical and cooperative roles of IL-4, IL-13, and IL-31 in sustaining chronic itch and inflammation in prurigo nodularis.
Explore the hierarchical and...
03/10/2026
The Dermatologist
Quiz
Type 2 Inflammation as a Pathogenic Driver in Prurigo Nodularis
03/05/2026
Riya Gandhi, MA
Test your understanding of how type 2 immune signaling drives chronic itch in prurigo nodularis through complex neuroimmune interactions.
Test your understanding of how type 2 immune signaling drives chronic itch in prurigo nodularis through complex neuroimmune interactions.
Test your understanding of how...
03/05/2026
The Dermatologist
psoriasis
Quiz
Distinguishing Feature of Generalized Pustular Psoriasis
03/02/2026
Jessica Garlewicz
What is a key distinguishing feature of generalized pustular psoriasis that differentiates it from plaque psoriasis?
What is a key distinguishing feature of generalized pustular psoriasis that differentiates it from plaque psoriasis?
What is a key distinguishing...
03/02/2026
The Dermatologist
psoriasis
Quiz
Quiz: Misdiagnosis of Generalized Pustular Psoriasis
03/02/2026
Jessica Garlewicz
What is the reason generalized pustular psoriasis is often misdiagnosed?
What is the reason generalized pustular psoriasis is often misdiagnosed?
What is the reason generalized...
03/02/2026
The Dermatologist
Quiz
Allergic Disease Progression: Genetics and Environment
02/26/2026
Riya Gandhi, MA
Explore the relationship between allergic disease trends, genetic timelines, and the clinical framework used to describe the progression of atopic conditions across childhood.
Explore the relationship between allergic disease trends, genetic timelines, and the clinical framework used to describe the progression of atopic conditions across childhood.
Explore the relationship between...
02/26/2026
The Dermatologist
Quiz
Early Intervention Strategies in Pediatric Atopic Dermatitis
02/26/2026
Riya Gandhi, MA
Assess your understanding of early skin barrier interventions in infants and the clinical rationale for prompt treatment of atopic dermatitis in young children, including implications for long-term disease outcomes.
Assess your understanding of early skin barrier interventions in infants and the clinical rationale for prompt treatment of atopic dermatitis in young children, including implications for long-term disease outcomes.
Assess your understanding of...
02/26/2026
The Dermatologist

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use